| Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine C Keech, G Albert, I Cho, A Robertson, P Reed, S Neal, JS Plested, M Zhu, ... New england journal of medicine 383 (24), 2320-2332, 2020 | 1294 | 2020 |
| Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a … PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ... Jama 320 (10), 984-994, 2018 | 642 | 2018 |
| Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs ML Grayson, SM Crowe, JS McCarthy, J Mills, JW Mouton, SR Norrby, ... CRC press, 2010 | 346* | 2010 |
| Use of matrix-assisted laser desorption ionization–time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak PM Griffin, GR Price, JM Schooneveldt, S Schlebusch, MH Tilse, ... Journal of clinical microbiology 50 (9), 2918-2931, 2012 | 236 | 2012 |
| A multinational Delphi consensus to end the COVID-19 public health threat JV Lazarus, D Romero, CJ Kopka, SA Karim, LJ Abu-Raddad, G Almeida, ... Nature 611 (7935), 332-345, 2022 | 193 | 2022 |
| A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs JS McCarthy, S Sekuloski, PM Griffin, S Elliott, N Douglas, C Peatey, ... PloS one 6 (8), e21914, 2011 | 170 | 2011 |
| Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study The Lancet, Infectious Diseases 17 (6), 626, 2017 | 130 | 2017 |
| Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™) GJP Fernando, J Hickling, CMJ Flores, P Griffin, CD Anderson, ... Vaccine 36 (26), 3779-3788, 2018 | 116 | 2018 |
| Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study A Henderson, DL Paterson, MD Chatfield, PA Tambyah, DC Lye, PP De, ... Clinical Infectious Diseases 73 (11), e3842-e3850, 2021 | 115 | 2021 |
| Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy Volunteers JS McCarthy, PM Griffin, S Sekuloski, AT Bright, R Rockett, D Looke, ... The Journal of infectious diseases 208 (10), 1688-1694, 2013 | 113 | 2013 |
| A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study JS McCarthy, T Rückle, E Djeriou, C Cantalloube, D Ter-Minassian, ... Malaria journal 15, 1-9, 2016 | 110 | 2016 |
| A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults AO Aliprantis, CA Shaw, P Griffin, N Farinola, RA Railkar, X Cao, W Liu, ... Human vaccines & immunotherapeutics 17 (5), 1248-1261, 2021 | 107 | 2021 |
| Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial KJ Chappell, FL Mordant, Z Li, DK Wijesundara, P Ellenberg, ... The Lancet Infectious Diseases 21 (10), 1383-1394, 2021 | 98 | 2021 |
| Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human … EG Playford, T Munro, SM Mahler, S Elliott, M Gerometta, KL Hoger, ... The Lancet Infectious Diseases 20 (4), 445-454, 2020 | 88 | 2020 |
| Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers JS McCarthy, M Baker, P O'Rourke, L Marquart, P Griffin, ... Journal of Antimicrobial Chemotherapy 71 (9), 2620-2627, 2016 | 80 | 2016 |
| Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial S Sekuloski, MR Batzloff, P Griffin, W Parsonage, S Elliott, J Hartas, ... PLoS One 13 (7), e0198658, 2018 | 79 | 2018 |
| Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of … CJ Pasay, R Rockett, S Sekuloski, P Griffin, L Marquart, C Peatey, ... The Journal of infectious diseases 214 (1), 105-113, 2016 | 69 | 2016 |
| Plasmodium vivax controlled human malaria infection–progress and prospects RO Payne, PM Griffin, JS McCarthy, SJ Draper Trends in parasitology 33 (2), 141-150, 2017 | 66 | 2017 |
| Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo … RM Mallory, N Formica, S Pfeiffer, B Wilkinson, A Marcheschi, G Albert, ... The Lancet Infectious Diseases 22 (11), 1565-1576, 2022 | 63 | 2022 |
| The dynamics of liver function test abnormalities after malaria infection: a retrospective observational study J Woodford, GD Shanks, P Griffin, S Chalon, JS McCarthy The American journal of tropical medicine and hygiene 98 (4), 1113, 2018 | 61 | 2018 |
Ian FrazerThe University of Queensland在 uq.edu.au 的电子邮件经过验证
